ALAB Stock Analysis: Astera Labs | NASDAQ

Semiconductors | NASDAQ, USA | Market Cap: 39.814m USD | 12M Return: 53.6% | US04626A1034 | Charts, Fundamentals & Technical Analysis

Retimers, Cable Modules, Memory Controllers, Fabric Switches
Total Rating 47
Safety 31
Buy Signal 0.62
Semiconductors
Sub-Industry Rotation: -28.1
Market Cap: 39.8B
Avg Turnover: 1.09B
Risk 3d forecast
Volatility107%
VaR 5th Pctl17.5%
VaR vs Median-0.70%
Reward TTM
Sharpe Ratio0.89
Rel. Str. IBD73.1
Rel. Str. Peer Group75 pctl
Character TTM
Beta3.961
Beta Downside2.893
Hurst Exponent0.434
Choppyness65.5%
Drawdowns 3y
Max DD63.69%
CAGR/Max DD0.97
CAGR/Mean DD2.06
EPS (Earnings per Share) EPS (Earnings per Share) of ALAB over the last years for every Quarter: "2022-03": null, "2022-06": null, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": null, "2023-09": null, "2023-12": 0.12, "2024-03": 0.27, "2024-06": 0.13, "2024-09": 0.23, "2024-12": 0.37, "2025-03": 0.33, "2025-06": 0.44, "2025-09": 0.49, "2025-12": 0.58, "2026-03": 0.61, "2026-06": 0.49, "2026-09": 0.99,
Last SUE: 4.00
Qual. Beats: 6
Revenue Revenue of ALAB over the last years for every Quarter: 2022-03: 15.018, 2022-06: 21.396, 2022-09: 23.103, 2022-12: 20.355, 2023-03: 17.664, 2023-06: 10.688, 2023-09: 36.928, 2023-12: 50.514, 2024-03: 65.258, 2024-06: 76.85, 2024-09: 113.086, 2024-12: 141.096, 2025-03: 159.442, 2025-06: 191.925, 2025-09: 230.575, 2025-12: 270.583, 2026-03: 308.361, 2026-06: 392.4, 2026-09: 584.899,
Rev. CAGR: 144.74%
Rev. Trend: 99.1%
Last SUE: 4.00
Qual. Beats: 7

Warnings

P/E Ratio 90.0
Beneish M-Score Likely Earnings Manipulation
Below Sma 200d

Tailwinds

Idiosyncratic Leader
Pead
Confidence

Seasonality 2.6 years of data, until 10/2026

Jan -22.6% 10
Feb -30.3% 10
Mar -19.1% 10
Apr +19.1% 20
May +34.2% 0
Jun -2.3% 0
Jul -24.5% 0
Aug +2.4% 20
Sep +26.8% 20
Oct -7.1% 0
Nov +8.1% 0
Dec +10.3% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: ALAB Astera Labs

Astera Labs, Inc. (NASDAQ: ALAB) is a U.S.-based fabless semiconductor company that designs, manufactures (via external foundries), and sells high-speed connectivity solutions purpose-built for cloud and AI infrastructure. Its core offering is the Astera Intelligence Connectivity Platform, a semiconductor-based, mixed-signal portfolio that integrates microcontrollers, sensors, and the COSMOS software suite for fleet-level management and optimization. The company sells primarily to hyperscalers and system original equipment manufacturers, with revenue concentrated in Taiwan and the United States.

The product portfolio spans PCIe/CXL smart DSP retimers and cable modules, ethernet smart cable modules for AI and cloud workloads, CXL memory connectivity controllers, and smart fabric switches. These products sit at the critical data-movement layer inside AI server racks, where high-bandwidth, low-latency interconnects between GPUs, accelerators, memory, and networking gear are essential. The connectivity semiconductor segment has been a structural beneficiary of hyperscaler capital expenditure on AI data centers, as larger GPU clusters require more retimers, optical interconnects, and switching fabric per rack.

Founded in 2017 and headquartered in San Jose, California, Astera Labs went public on March 20, 2024, and is classified within the Information Technology sector and Semiconductors sub-industry under the GICS taxonomy. As a fabless designer, the company outsources wafer fabrication and focuses internal resources on chip design, validation, and software-a model common among U.S. semiconductor firms that allows for higher gross margins but creates reliance on third-party foundries.

Headlines to Watch Out For
  • AI server buildouts drive retimer and fabric switch demand
  • Hyperscaler customer concentration exposes revenue to capex volatility
  • Broadcom and Marvell competition pressures AI connectivity market share
Piotroski VR-10 (Strict) 3.0
Net Income: 461.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.39 > 1.0
NWC/Revenue: 110.0% < 20% (prev 164.5%; Δ -54.49% < -1%)
CFO/TA 0.19 > 3% & CFO 436.7m > Net Income 461.3m
Net Debt (-1.34b) to EBITDA (449.7m): -2.98 < 3
Current Ratio: 8.03 > 1.5 & < 3
Outstanding Shares: last quarter (184.1m) vs 12m ago 1.91% < -2%
Gross Margin: 73.89% > 18% (prev 75.41%; Δ -1.52% > 0.5%)
Asset Turnover: 84.09% > 50% (prev 51.60%; Δ 32.48% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 10.00
A: 0.74 (Total Current Assets 1.96b - Total Current Liabilities 243.6m) / Total Assets 2.30b
B: 0.19 (Retained Earnings 426.7m / Total Assets 2.30b)
C: 0.23 (EBIT TTM 434.2m / Avg Total Assets 1.85b)
D: 6.65 (Book Value of Equity 2.00b / Total Liabilities 300.9m)
Altman-Z'' = 14.04 = AAA
Beneish M 0.51
DSRI: 3.0 (Receivables 284.3m/42.9m, Revenue 1.56b/723.0m)
GMI: 1.02 (GM 75.41% / 73.89%)
AQI: 2.76 (AQ_t 0.08 / AQ_t-1 0.03)
SGI: 2.15 (Revenue 1.56b / 723.0m)
TATA: 0.01 (NI 461.3m - CFO 436.7m) / TA 2.30b)
Beneish M = 0.51 (Cap -4..+1) = D
What is the price of ALAB shares?

As of November 15, 2026, the stock is trading at USD 221.83 with a total of 4,073,713 shares traded. Over the past week, the price has changed by +16.32%, over one month by -31.83%, over three months by -31.28% and over the past year by +53.55%.

Current recommended Stop Loss: 162.70 (which is 26.7% or 2.4 ATR below the current price).

Is ALAB a buy, sell or hold?

Astera Labs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy ALAB.

  • StrongBuy: 12
  • Buy: 6
  • Hold: 7
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the ALAB price?
Analysts Target Price 344.2 55.1%
Astera Labs (ALAB) - Fundamental Data Overview as of 14 November 2026
Market Cap USD = 39.8b (39.8b USD * 1.0 USD.USD)
P/E Trailing = 90.0356
P/E Forward = 34.0136
P/S = 25.5832
P/B = 20.1848
Revenue TTM = 1.56b USD
EBIT TTM = 434.2m USD
EBITDA TTM = 449.7m USD
 Long Term Debt = unknown (none)
 Short Term Debt = unknown (none)
 Debt = 39.3m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 4.15m
Net Debt = -1.34b USD (calculated: Debt 39.3m - CCE 1.38b)
Enterprise Value = 38.5b USD (39.8b + Debt 39.3m - CCE 1.38b)
 Interest Coverage Ratio = unknown (Ebit TTM 434.2m / Interest Expense TTM 0.0)
 EV/FCF = 111.6x (Enterprise Value 38.5b / FCF TTM 344.7m)
FCF Yield = 0.90% (FCF TTM 344.7m / Enterprise Value 38.5b)
FCF Margin = 22.15% (FCF TTM 344.7m / Revenue TTM 1.56b)
Net Margin = 29.64% (Net Income TTM 461.3m / Revenue TTM 1.56b)
Gross Margin = 73.89% ((Revenue TTM 1.56b - Cost of Revenue TTM 406.3m) / Revenue TTM)
Gross Margin QoQ = 72.28% (prev 73.28%)
Tobins Q-Ratio = 16.73 (Enterprise Value 38.5b / Total Assets 2.30b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 39.3m)
Taxrate = 4.73% (9.08m / 192.0m)
NOPAT = 413.7m (EBIT 434.2m * (1 - 4.73%))
Current Ratio = 8.03 (Total Current Assets 1.96b / Total Current Liabilities 243.6m)
Debt / Equity = 0.02 (Debt 39.3m / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = -2.98 (Net Debt -1.34b / EBITDA 449.7m)
Debt / FCF = -3.88 (Net Debt -1.34b / FCF TTM 344.7m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 24.93% (Net Income 461.3m / Total Assets 2.30b)
RoE = 28.03% (Net Income TTM 461.3m / Total Stockholder Equity 1.65b)
RoCE = 21.11% (EBIT 434.2m / Capital Employed (Total Assets 2.30b - Current Liab 243.6m))
RoIC = 20.90% (NOPAT 413.7m / Invested Capital 1.98b)
WACC = 18.90% (E(39.8b)/V(39.9b) * Re(18.92%) + D(39.3m)/V(39.9b) * Rd(0.0%) * (1-Tc(0.05)))
Discount Rate = 18.92% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 81.88 | Cagr: 7.88%
[DCF] Terminal Value 51.05% ; FCFF base≈298.6m ; Y1≈342.3m ; Y5≈503.8m
[DCF] Fair Price = 22.51 (EV 2.60b - Net Debt -1.34b = Equity 3.93b / Shares 174.8m; r=18.90% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 4.0 | # QB: 6
Revenue Correlation: 99.14 | Revenue CAGR: 144.7% | SUE: 4.0 | # QB: 7
EPS current Quarter (2027-03-31): EPS=1.67 | Chg30d=+14.20% | Revisions=+25% | Analysts=20
EPS current Year (2026-12-31): EPS=4.38 | Chg30d=+8.47% | Revisions=+40% | GrowthEPS=+138.1% | GrowthRev=+137.8%
EPS next Year (2027-12-31): EPS=7.15 | Chg30d=+11.86% | Revisions=+40% | GrowthEPS=+63.2% | GrowthRev=+67.1%
[Analyst] Revisions Ratio: +62% (up=5, down=0)